CURE
Direxion Daily Healthcare Bull 3x Shares·NYSE
--
--(--)
--
--(--)
Key Stats
Assets Under Management
173.83MUSD
Fund Flows (1Y)
-72.86MUSD
Dividend Yield
1.09%
Discount/Premium to NAV
-0.45%
Shares Outstanding
1.50M
Expense Ratio
0.93%
About Direxion Daily Healthcare Bull 3x Shares
Issuer
Rafferty Asset Management, LLC
Brand
Direxion
Inception Date
Jun 15, 2011
Structure
Open-Ended Fund
Index Tracked
Health Care Select Sector Index
Management Style
Passive
Dividend Treatment
Distributes
Distribution Tax Treatment
Ordinary income
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
Rafferty Asset Management LLC
Distributor
Foreside Fund Services LLC
As a levered product, CURE is not a buy-and-hold ETF, it's a short-term tactical instrument. Like many levered funds, it delivers 3x exposure only for one day. Over longer periods, returns can vary significantly from 3x of its underlying index, which covers some of the biggest healthcare names—like J&J, Pfizer, and Merck—in the space, and those heavyweights comprise a large share of CURE's cap-weighted, S&P 500-only portfolio. As a short-term product, CURE's expense ratio is less important than all in trading costs. Trading can be volatile. Check the latest Tradability data on this page.
Classification
Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Broad-based
Strategy
Vanilla
Geography
U.S.
Weighting Scheme
Market Cap
Selection Criteria
Committee
Returns
1-Month | 3-Month | YTD | 1-Year | 3-Year | 5-Year | |
|---|---|---|---|---|---|---|
Price Performance | -3.50% | +22.37% | +3.15% | +1.20% | +10.38% | +41.18% |
NAV Total Return | -4.97% | +22.16% | +2.61% | +7.80% | +14.80% | +49.41% |
Ratings
No data is currently available
Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis
Sector
Healthcare
100.00%
Healthcare
100.00%
Asset
Region
100%
Category
Ratio
North America
100.00%
Investment Style
Mega
Large
Medium
Multi
Small
Value
Blend
Growth
Large-Cap Growth
Focuses on large-cap companies with high growth potential. These ETFs invest in leading companies with strong expansion prospects.
Top 10 Holdings
Symbol
Ratio
HEALTH CARE SELECT SECTOR INDEX SWAP
67.63%
GOLDMAN FINL SQ TRSRY INST 506
11.98%
DREYFUS GOVT CASH MAN INS
11.92%
LLY
Eli Lilly
11.24%
JNJ
Johnson & Johnson
7.95%
ABBV
Abbvie
5.37%
MRK
Merck
4.12%
UNH
UnitedHealth Group
3.37%
TMO
Thermo Fisher
2.83%
AMGN
Amgen
2.75%
Top 10 Weight 129.15%
64 Total Holdings
Is SPY better than CURE?
Dividends
Dividend Payout History
Declaration Date | Record Date | Payment Date | Amount |
|---|---|---|---|
| 2025-12-23 | 2025-12-23 | 2025-12-31 | 0.291 |
| 2025-09-23 | 2025-09-23 | 2025-09-30 | 0.310 |
| 2025-06-24 | 2025-06-24 | 2025-07-01 | 0.305 |
| 2025-03-25 | 2025-03-25 | 2025-04-01 | 0.345 |
| 2024-12-23 | 2024-12-23 | 2024-12-31 | 0.116 |
| 2024-09-24 | 2024-09-24 | 2024-10-01 | 0.333 |
| 2024-06-25 | 2024-06-25 | 2024-07-02 | 0.273 |
Show more
How Much Does CURE Pay in Dividends?
Premium/Discount Chart
Assets Under Management
Should I buy CURE?
Fund Flows
